Climb Bio Inc - CLYM Company Short-Term Debt

Graphic logo of Climb Bio Inc (CLYM)

The price history on the Climb Bio Inc (CLYM) chart demonstrates the asset's dynamics, where the specific short-term debt metric is fixed at 0.00. The business is protected by patent law and the complexity of FDA certification, which blocks access for smaller players. Climb Bio Inc (CLYM) creates unique antibodies for the therapy of renal pathologies, aiming to avoid harsh chemicals to extend the lives of patients with chronic diagnoses.

CLYM (Climb Bio Inc.) Company Short-Term Debts history from 10/04/2024 to 10/28/2026

Climb Bio, Inc - analytical breakdowns and key metrics (CLYM)

- price and consensus price forecast:
Price Chart Climb Bio|CLYM - Fair Value Consensus
- market capitalization data:
Market Value Climb Bio Inc.|CLYM - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Climb Bio|CLYM - Book Capitalization|Market Cap to Net Assets Ratio climbbio.com|CLYM - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Climb Bio Inc|CLYM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Climb Bio Inc|CLYM - Company Total Debt|Debt to Book Capitalization Ratio Climb Bio Inc.|CLYM - Company Long-Term Liabilities|Company Current Liabilities Climb Bio
Fundamental company valuation:Climb Bio - CLYM
Product sample of Climb Bio Inc

Short-term debt determines the capital stability and liquidity levels of Climb Bio Inc (CLYM) amid market volatility. This metric aggregates all obligations with a maturity of up to one year to assess the risk of cash shortages. By analyzing short-term debt statistics, an investor can discern the balance between leveraged financing and financial autonomy. For Climb Bio Inc (CLYM), this indicator is critical when developing targeted drugs, as optimizing loans ensures the stable advancement of innovations in the therapy of autoimmune pathologies.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|UPB: Company Short-Term Debts|ZBIO: Company Current Liabilities|Immunome, Inc. (IMNM) - Company Short-Term Debt|gossamerbio.com (GOSS) - Company Short-Term Debt|KALV: Company Short-Term Debts|Short-Term Debt Volume SEPN|Company Short-Term Debt PVLA (Pieris Pharmaceuticals Inc)|Company Current Liabilities Savara Pharma (SVRA)|Company Short-Term Debts Rigel Pharmaceuticals RIGL|ANAB - Company Short-Term Debt|Company Current Liabilities Astria Therapeutics, Inc. (ATXS)|ENGN - Company Short-Term Loans and Borrowings|RAPT Therapeutics (RAPT) - Company Short-Term Debts|Aerovate Therapeutics (JBIO) - Company Short-Term Debt|ACRS: Company Short-Term Debts|Short-Term Debt Volume KYTX|Tiziana Life Sciences Ltd - Company Short-Term Debt|Short-Term Debt Cabaletta Bio Inc. CABA|Company Current Liabilities Ventyx Bio|Company Short-Term Loans and Borrowings Theratechnologies, Inc THTX|Company Short-Term Debts AVTX (Avalo Therapeutics, Inc)|ELDN: Short-Term Debt Volume|Company Short-Term Debt Agenus Inc.|zurabio.com (ZURA) - Company Short-Term Indebtedness|Company Short-Term Debts ATYR|Company Current Liabilities Adagene Corp|Company Short-Term Debts IMA (ImageneBio Inc)|Company Current Liabilities STTK (shattucklabs.com)|Company Short-Term Debt Equillium EQ|CNTB - Company Short-Term Debt|IMUX (Immunic Inc) - Company Current Liabilities|ATRA: Short-Term Debt|IFRX (inflarx.de) - Company Short-Term Debt|XFOR (x4pharma.com) - Company Current Liabilities|Company Short-Term Debt Adicet Bio Inc. ACET|Current Liabilities Celularity Corp|INmune Bio Corp (INMB) - Company Short-Term Debts|Company Short-Term Loans and Borrowings Barinthus Biotherapeutics Corp (BRNS)|Company Short-Term Debts KZR (Kezar Life Sciences)|sabbiotherapeutics.com - Company Short-Term Debts|Company Short-Term Debt Akari Therapeutics Plc (AKTX)|ENLV: Company Short-Term Loans and Borrowings|QTTB (q32bio.com) - Company Short-Term Debt|GeoVax Corp (GOVX) - Company Current Liabilities|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Company Short-Term Debts ibioinc.com (IBIO)|Carisma Therapeutics (CARM) - Company Current Liabilities|Company Short-Term Loans and Borrowings XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts BOLT|HCW Biologics, Inc. - Short-Term Debt Volume|APVO: Company Short-Term Debt|AIM: Company Current Liabilities|ADTX (aditxt.com) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|XRTX (XORTX) - Company Current Liabilities|Company Short-Term Debts HIND|Company Short-Term Debt Revelation Biosciences REVB|Company Short-Term Indebtedness indaptusrx.com (INDP)|SCNI: Company Short-Term Debts|Short-Term Debt CalciMedica Inc CALI|AFMD: Company Short-Term Debts|ALLK: Company Current Liabilities|hookipapharma.com (HOOK) - Company Short-Term Debt|IGM Biosciences (IGMS) - Company Short-Term Debt|ITOS: Company Short-Term Debts|Short-Term Debt Volume OCEA|Company Short-Term Debt TCBP (TC BioPharm (Holdings) PLC)|Company Current Liabilities Third Harmonic Bio Inc (THRD)